Anders Lundqvist
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Dermatology top 5%
- Dermatological and COVID-19 studies
Papers in
-
- Drug Solubulity and Delivery Systems 10
- Advanced Drug Delivery Systems 7
-
- Parvovirus B19 Infection Studies 8
- Co-authors
- Kalle Sigfridsson (6 shared papers)Christer Tannergren (7 shared papers)Hans Lennernäs (7 shared papers)Erik Sjögren (7 shared papers)David Dahlgren (7 shared papers)Markus Fridén (5 shared papers)Owe Orwar (4 shared papers)Markus Sjöblom (5 shared papers)
- Journals
- Infectious Diseases (3 papers)Molecular Pharmaceutics (3 papers)British Journal of Pharmacology (2 papers)Journal of Pharmaceutical Sciences (2 papers)Analytical Chemistry (2 papers)
- Partner nations
- SwedenUnited KingdomGermany
In The Last Decade
Anders Lundqvist
46 papers receiving 917 citations
Peers
Comparison fields: 5 of 109
- Pharmaceutical Science 276
- Dermatology 99
- Infectious Diseases 154
- Applied Microbiology and Biotechnology 14
- Oncology 173
Countries citing papers authored by Anders Lundqvist
This map shows the geographic impact of Anders Lundqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Lundqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Lundqvist more than expected).
Fields of papers citing papers by Anders Lundqvist
This network shows the impact of papers produced by Anders Lundqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Lundqvist. The network helps show where Anders Lundqvist may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Lundqvist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 67 | |
| 2 | 2009 | 63 | |
| 3 | 2016 | 62 | |
| 4 | 2016 | 58 | |
| 5 | 2018 | 45 | |
| 6 | 2003 | 44 | |
| 7 | 2017 | 39 | |
| 8 | 2015 | 38 | |
| 9 | 2016 | 34 | |
| 10 | 1999 | 34 | |
| 11 | 1999 | 33 | |
| 12 | 2017 | 31 | |
| 13 | 2011 | 30 | |
| 14 | 2017 | 30 | |
| 15 | 2018 | 30 | |
| 16 | 2010 | 28 | |
| 17 | 1997 | 25 | |
| 18 | 2005 | 24 | |
| 19 | 2016 | 22 | |
| 20 | 2018 | 22 |
About Anders Lundqvist
Anders Lundqvist is a scholar working on Pharmaceutical Science, Infectious Diseases, Pulmonary and Respiratory Medicine, Oncology and Biomedical Engineering, having authored 48 papers that have together received 956 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (10 papers), Parvovirus B19 Infection Studies (8 papers), Drug Transport and Resistance Mechanisms (8 papers), Inhalation and Respiratory Drug Delivery (7 papers), Advanced Drug Delivery Systems (7 papers), Dermatological and COVID-19 studies (6 papers), Asthma and respiratory diseases (5 papers) and Advanced Chemical Sensor Technologies (4 papers). The work is most often cited by research in Pharmaceutical Science (276 citations), Dermatology (99 citations), Infectious Diseases (154 citations), Applied Microbiology and Biotechnology (14 citations) and Oncology (173 citations). Anders Lundqvist has collaborated with scholars based in Sweden, United Kingdom and Germany. Frequent co-authors include Kalle Sigfridsson, Christer Tannergren, Hans Lennernäs, Erik Sjögren, David Dahlgren, Markus Fridén, Owe Orwar, Markus Sjöblom, Christian Roos and Carl Roos. Their work appears in journals such as Infectious Diseases, Molecular Pharmaceutics, British Journal of Pharmacology, Journal of Pharmaceutical Sciences and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.